Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: An experimental study

European Journal of Vascular and Endovascular Surgery

Volumn 23, Issue 2, 2002, Pages 127-133

  Lehnhardt, F J ^a   Torsello, G ^b   Claeys, L G Y ^c   Pfeiffer, M ^a   Wachol Drewek, Z ^a   Grundmann, R T ^a   Sandmann, W ^d  

^a B Braun Melsungen AG   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Local antibiotic prophylaxis; Perioperative antibiotic prophylaxis; Rifampicin; Vascular graft infection

Indexed keywords

CEFAMANDOLE; RIFAMPICIN; POLYETHYLENE TEREPHTHALATE;

ABSCESS; ANASTOMOSIS; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD VESSEL PROSTHESIS; CONTROLLED STUDY; DACRON IMPLANT; DOG; DOSE RESPONSE; GRAFT INFECTION; GRAFT OCCLUSION; NONHUMAN; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; PROSTHESIS INFECTION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; ANIMAL; AORTA VALVE; AUTOPSY; BIOLOGICAL MODEL; COMPARATIVE STUDY; DISEASE MODEL; HEART VALVE PROSTHESIS; INFECTION; PATHOLOGY; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIBIOTIC PROPHYLAXIS; AORTIC VALVE; AUTOPSY; DISEASE MODELS, ANIMAL; DOGS; HEART VALVE PROSTHESIS; MODELS, CARDIOVASCULAR; POLYETHYLENE TEREPHTHALATES; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS;

EID: 0036480324     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1571     Document Type: Article

References (47)

1. GOLDSTONE J, MOORE WS. Infection in vascular prosthesis: clinical manifestations and surgical management. Am J Surg 1974; 128: 225-233.
2. LIEKWIG WG, GREENFIELD LJ. Vascular prosthetic infections: collected experience and results of treatment. Surgery 1977; 81: 335-342.
3. BUNT TJ. Synthetic vascular graft infections I. Graft Infections. Surgery 1983; 93: 733-746.
4. FLETCHER JP, DRYDEN M, SORRELL TC. Infection of vascular prostheses. Aust NZ J Surg 1991; 61: 432-435.
5. O'BRIEN T, COLLIN J. Prosthetic vascular graft infection. Br J Surg 1992; 79: 1262-1267.
6. CLAGETT GP, BOWERS BL, LOPEZ-VIEGO MA et al. Creation of neoaortoiliac system from lower extremity deep and superficial veins. Ann Surg 1993; 218: 239-248.
7. GRECO RS. Utilizing vascular prostheses for drug delivery. Eur J Vase Surg 1991; 5: 753-757.
8. ABBOTT WM, CALLOW A, MOORE WS et al. Evaluation and performance standards for arterial prostheses. J Vasc Surg 1993; 17: 746-756.
9. CALLIGARO KD, VEITH FJ. Diagnosis and management of infected prosthetic aortic graft. Surgery 1991; 110: 805-813.
10. KIKTA MJ, GOODMAN LJ, BISHARA RA. Mortality and limb loss with infected infrainguinal bypass grafts. J Vasc Surg 1987; 5: 566-571.
11. BANDYK DF, BERNI GA, THIELE BL, TOWNE JB. Aortofemoral graft infection due to Staphylococcus epidermidis. Arch Surg 1984; 119: 102-108.
12. LORENTZEN JE, NIELSEN OM, ARENDRUP H et al. Vascular graft infection: an analysis of sixty-two infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 1985; 98: 81-86.
13. CALLIGARO KD, VEITH FJ, SCHWARTZ ML, SAVARESE RP, DE-LAURENTIS DA. Are gram-negative bacteria a contraindication to selective preservation of infected prosthetic arterial grafts? J Vasc Surg 1992; 16: 337-345.
14. SZILAGYI DE, SMITH RF, ELLIOTT JP, VRANDEDH NP. Infection in arterial reconstruction with synthetic grafts. Am Surg 1972; 176: 321-333.
15. MACBETH GA, RUBIN JR, MCINTYRE EE et al. The relevance of arterial wall microbiology to the treatment of prosthetic graft infections: graft infection versus arterial infection. J Vasc Surg 1984; 1: 750-756.
16. KAISER AB, CLAYSON KR, MULHERIN JL et al. Antibiotic prophylaxis in vascular surgery. Ann Surg 1978; 188: 283-289.
17. PITT HA, POSTIER RG, MCGOWAN WA et al. Prophylactic antibiotics in vascular surgery. A prospective randomised double blind study. Ann Surg 1980; 192: 356-364.
18. RUTLEDGE R, BAKER V, SHERETZ R, JOHNSON G. Rifampin and cefazolin as prophylactic agents. Arch Surg 1982; 117: 2264-2265.
19. HASSELGREN PO, IVARSSON L, RISBERG B, SEEMAN T. Effects of prophylactic antibiotics in vascular surgery. A prospective randomised double blind study. Ann Surg 1984; 200: 86-92.
20. SANTINI C, BAIOCCHI P, SERRA P. Perioperative antibiotic prophylaxis in vascular surgery. Eur J Vasc Endovasc Surg 1997; 14 (Suppl. A): 13-14.
21. POWELL TW, BURNHAM SJ, JOHNSON G. A passive system using rifampin to create an infection resistant vascular prosthesis. Surgery 1983; 94: 765-769.
22. MCDOUGALL EG, BURNHAM SJ, JOHNSON G. Rifampicin protection against experimental graft sepsis. J Vasc Surg 1986; 4: 5-7.
23. SHUE WB, WOROSILO SC, DONETZ AP et al. Prevention of vascular prosthetic infection with an antibiotic bonded Dacron graft. J Vasc Surg 1988; 8: 600-605.
24. AVRAMOVIC J, FLETCHER JP. Rifampicin impregnation of a protein-sealed Dacron graft: an infection resistant prosthetic vascular graft. Austr NZ J Surg 1991; 61: 436-440.
25. AVRAMOVIC J, FLETCHER JP. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg 1992; 33: 70-74.
26. HAVERICH A, HIRT ST, KARCK M, SICLARI F, WAHLIG H. Prevention of graft infection by bonding of gentamycin to Dacron prostheses. J Vasc Surg 1992; 15: 187-193.
27. SARDELIC F, AO PY, TAYLOR DA, FLETCHER JP. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron. Cardiovasc Surg 1996; 4: 389-392.
28. SARDELIC F, AO PY, FLETCHER JP. Rifampicin impregnated Dacron grafts: no development of rifampicin resistance in an animal model. Eur J Vasc Endovasc Surg 1995; 9: 314-318.
29. STRACHAN CJL, NEWSOM SWB, ASHTON TR. The clinical use of an antibiotic-bonded graft. Eur J Vasc Surg 1991; 5: 627-632.
30. GOEAU-BRISSONIÈRE O, PECHÈRE JC, GUIDON R, NOEL HP, COUTURE J. Experimental colonisation of vascular grafts with Staphylococcus aureus. Can J Surg 1983; 26: 540-545.
31. SHAH PM, ITO K, CLAUSS RH et al. Expanded microporous polytetrafluoroethylene (PTFE) grafts in contaminated wounds: experimental and clinical study. J Trauma 1983; 23: 1030-1033.
32. SOBINSKY KR, FLANIGAN DP. Antibiotic binding to polytetrafluoroethylene via glycosaminoglycan keratin luminal coating. Surgery 1986; 100: 629-634.
33. MOORE WS, CHVAPIL M, SEIFFERT G, KEOWN K. Development of an infection resistant vascular prosthesis. Arch Surg 1981; 116: 1403-1407.
34. SHENK JS, NEY AL, TSUKAYAMA DT, OLSON ME, BUBRICK MP. Tobramycin-adhesive in preventing and treating PTFE vascular graft infections. Surg Res 1989; 47: 487-492.
35. CHERVU A, MOORE WS, CHVAPIL M, HENDERSON T. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg 1991; 13: 897-901.
36. OKAHARA K, KAMBAYASHI J, SHIBUVA T et al. An infection-resistant PTFE vascular graft: spiral coiling of the graft with ofloxacin-bonded PTFE thread. Eur J Vasc Endovasc Surg 1995; 9: 408-414.
37. MUHL E, GATERMANN S, IVEN H, DENDORFER A, BRUCH HP. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model. Ann Vasc Surg 1996; 10: 244-253.
38. FARR B, MANDELL GL. Rifampicin. Med Clin N Am 1982; 66: 157-168.
39. SARDELIC F, AO PY, FLETCHER JP. Efficacy of rifampicin impregnated graft in reducing methicillin resistant staphylococcus aureus vascular graft infection in a sheep model. Surg Res Comm 1994; 15: 205-210.
40. CHERVU A, MOORE WS, GELABERT HA, COLBURN MD, CHVAPIL M. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg 1991; 14: 521-525.
41. FLETCHER JP, VICARETTI M. Prevention of prosthetic vascular graft infection. In: Nicolaides A, Novo S, eds. Advances in Vascular Pathology. Amsterdam: Elsevier Science B.V., 1997: 89-100.
42. COLBUM MD, MOORE WS, CHVAPIL M, GELABERT HA, QUIÑONES-BALDRICH WJ. Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections. J Vasc Surg 1992; 16: 651-660.
43. FREYRIE A, CURTI T, RODIO M et al. Interaction between vascular prostheses and rifampicin in the prevention of graft infection. Int Angiol 1992; 11: 113-116.
44. GOËAU-BRISSONNIèRE O, MERCIER F, NICOLAS MH et al. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg 1994; 19: 739-744.
45. D'ADDATO M, CURTI T, FREYRIE A AND THE ITALIAN INVESTIGATORS GROUP. Prophylaxis of graft infection with rifampicin-bonded gelseal graft: two-year follow-up of a prospective clinical trial. Cardiovasc Surg 1996; 4: 200-204.
46. D'ADDATO M, CURTI T, FREYRIE A. The rifampicin-bonded gelseal graft. Eur J Vasc Endovasc Surg 1997; 14 (Suppl. A): 15-17.
47. KOSKAS F, GOËAU-BRISSONNIèRE O, PECHÈRE JC. Prevention of early wound and graft infection with rifampicin-bonded knitted polyester-grafts: results of the rifampicin bonded grafts European trial (RBGET). Rifampicin Bonded Graft European Trial, Trial, Paris, 12-13 May, 1995.